IL6 and breast carcinoma: Elevated levels of inflammatory markers, such as Tumor Necrosis Factor-α (TNF-α), Interleukin-6 (IL-6), and neutrophils, have been observed in HR-positive breast cancer patients, suggesting their potential role as diagnostic indicators [13].